Abbott Laboratories Stock Rises 10.7%, Outperforms Peers

Dow Jones
07/17

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Abbott Laboratories jumped 10.7% to $98.83 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.5% to 7,533.77 and Dow Jones Industrial Average falling 0.2% to 52,552.97.

This was the stock's second consecutive day of gains.

Abbott Laboratories closed 28.1% below its 52-week high of $137.49, which the company achieved on September 22nd.

The stock outperformed some of its peers, as Johnson & Johnson rose 1.2% to $249.97, Pfizer Inc. rose 1.3% to $25.14, and Merck & Co. Inc. rose 3.25% to $127.63.

Trading volume totaled 31.2 million, compared to the 50-day average of 13.0 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

July 16, 2026 16:32 ET (20:32 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10